Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > SAVA Cassava Sciences > Detailed Quotes

SAVA Cassava Sciences

42.350
+1.380+3.37%
Close 10/06 16:00 ET
42.300
-0.050-0.12%
Post Mkt Price 10/06 19:41 ET
High
46.290
Open
40.700
Turnover
186.60M
Low
40.520
Pre Close
40.970
Volume
4.26M
Market Cap
1.70B
P/E(TTM)
Loss
52wk High
100.000
Shares
40.10M
P/E(Static)
Loss
52wk Low
13.840
Float Cap
1.55B
Bid/Ask %
45.95%
Historical High
146.160
Shs Float
36.51M
Volume Ratio
2.42
Historical Low
1.000
Dividend TTM
--
Div Yield TTM
--
P/B
7.78
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
11.67%
Amplitude
14.08%
Avg Price
43.781
Lot Size
1
Float Cap
1.55B
Bid/Ask %
45.95%
Historical High
146.160
Shs Float
36.51M
Volume Ratio
2.42
Historical Low
1.000
Dividend TTM
--
P/B
7.78
Dividend LFY
--
Turnover Ratio
11.67%
Amplitude
14.08%
Avg Price
43.781
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.
CEO: Mr. Remi Barbier
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...